Investment Watch is a quarterly publication delivering insights into equity strategy and economic trends. The Winter 2026 edition explores how the global economy enters Q3 2026 with the Iran conflict re-escalating, a reminder that the road to resolution is rarely straight. Markets have absorbed the renewed uncertainty better than many feared, reflecting the underlying resilience we have been backing all year.

Investment Watch is a quarterly publication produced by Morgans that delves into key insights for equity and economic strategy.

This edition arrives with the Iran conflict re-escalating, yet markets have absorbed the renewed uncertainty better than many feared. That resilience is why we stay the course. We see a strong second half for growth assets, powered by artificial intelligence, energy security and a global earnings cycle that keeps delivering.

The watchpoint is inflation. It is proving stickier than hoped, keeping interest rates higher for longer and rewarding investors who focus on income over speculation. We are optimistic, but clear eyed. The best returns in the second half will go to those who stay invested, stay diversified, and resist the temptation to sit on the sidelines.


Morgans clients receive exclusive insights such as access to our latest Investment Watch publication. Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Find out more
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
January 30, 2026
17
November
2023
2023-11-17
min read
Nov 17, 2023
ALS: Resilience Sets Up a Bright Future
Alexander Mees (AR: 001289080)
Alexander Mees (AR: 001289080)
Head of Research
ALS's FY23 success, surpassing earnings expectations with a 13.0% NPATA increase to $1,327M, sets the stage for a resilient future, navigating FY24 with optimism and retaining an Add rating despite adjustments.
Find out more
Research
January 30, 2026
17
November
2023
2023-11-17
min read
Nov 17, 2023
Nufarm: Resilient Performance
Belinda Moore (AR: 000259141)
Belinda Moore (AR: 000259141)
Senior Analyst
Explore how Nufarm outperformed peers in FY23, the strategic moves that shaped their financials, and what lies ahead in FY24.
Find out more
Research
January 30, 2026
17
November
2023
2023-11-17
min read
Nov 17, 2023
GrainCorp: Managing Strong Cash Position
Belinda Moore (AR: 000259141)
Belinda Moore (AR: 000259141)
Senior Analyst
GrainCorp's (ASX:GNC) FY23 result was down on the record pcp however it still posted a commendable result with strong operating cashflow and a large core cash position the key highlights.
Find out more
Research
Ramsay Health Care's investor day spotlighted digital aspirations and strategic manoeuvres. Explore promising growth in Australia, the delicate balance of operating leverage, and adjustments to FY24-26 earnings.
Find out more
Research
January 30, 2026
15
November
2023
2023-11-15
min read
Nov 15, 2023
Commonwealth Bank: Q1 Report Card
Nathan Lead (AR: 000431706)
Nathan Lead (AR: 000431706)
Senior Analyst
Insights into Commonwealth Bank's Q1 performance, highlighting strengths and areas for improvement.
Find out more
Research
January 30, 2026
2
November
2023
2023-11-02
min read
Nov 02, 2023
Morgans Best Ideas: November 2023
Andrew Tang (AR: 001007335)
Andrew Tang (AR: 001007335)
Equity Strategist
Explore Morgans' curated stock ideas for November 2023, highlighting high-growth potential and investment strategies.
Find out more
Research
No results found.